Literature DB >> 2997283

A distant gene deletion affects beta-globin gene function in an atypical gamma delta beta-thalassemia.

P Curtin, M Pirastu, Y W Kan, J A Gobert-Jones, A D Stephens, H Lehmann.   

Abstract

We describe an English family with an atypical gamma delta beta-thalassemia syndrome. Heterozygosity results in a beta-thalassemia phenotype with normal hemoglobin A2. However, unlike previously described cases, no history of neonatal hemolytic anemia requiring blood transfusion was obtained. Gene mapping showed a deletion that extended from the third exon of the G gamma-globin gene upstream for approximately 100 kilobases (kb). The A gamma-globin, psi beta-, delta-, and beta-globin genes in cis remained intact. The malfunction of the beta-globin gene on a chromosome in which the deletion is located 25 kb away suggests that chromatin structure and conformation are important for globin gene expression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997283      PMCID: PMC424127          DOI: 10.1172/JCI112136

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Gamma-beta thalassemia: a cause of hemolytic disease of the newborn.

Authors:  Y W Kan; B G Forget; D G Nathan
Journal:  N Engl J Med       Date:  1972-01-20       Impact factor: 91.245

Review 2.  Recent advances in the quantitation of human fetal hemoglobins with different gamma chains.

Authors:  T H Huisman; J B Wilson
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047

3.  Heterogeneity in the molecular basis of hereditary persistence of fetal haemoglobin.

Authors:  D Tuan; M J Murnane; J L deRiel; B G Forget
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

4.  Cloning and direct examination of a structurally abnormal human beta 0-thalassemia globin gene.

Authors:  S H Orkin; R Kolodner; A Michelson; R Husson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

5.  Cloning and characterization of DNA sequences surrounding the human gamma-, delta-, and beta-globin genes.

Authors:  R E Kaufman; P J Kretschmer; J W Adams; H C Coon; W F Anderson; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

Review 6.  The molecular genetics of human hemoglobin.

Authors:  F S Collins; S M Weissman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1984

7.  Characterisation of deletions which affect the expression of fetal globin genes in man.

Authors:  E F Fritsch; R M Lawn; T Maniatis
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

8.  Polymorphism of DNA sequence in the beta-globin gene region. Application to prenatal diagnosis of beta 0 thalassemia in Sardinia.

Authors:  Y W Kan; K Y Lee; M Furbetta; A Angius; A Cao
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

9.  gamma-beta-Thalassaemia studies showing that deletion of the gamma- and delta-genes influences beta-globin gene expression in man.

Authors:  L H Van der Ploeg; A Konings; M Oort; D Roos; L Bernini; R A Flavell
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

10.  Physical mapping of the globin gene deletion in hereditary persistence of foetal haemoglobin (HPFH).

Authors:  R Bernards; R A Flavell
Journal:  Nucleic Acids Res       Date:  1980-04-11       Impact factor: 16.971

View more
  30 in total

1.  DNase I hypersensitive site II of the human growth hormone locus control region mediates an essential and distinct long-range enhancer function.

Authors:  Margaret R Fleetwood; Yugong Ho; Nancy E Cooke; Stephen A Liebhaber
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Transcription of the hypersensitive site HS2 enhancer in erythroid cells.

Authors:  D Tuan; S Kong; K Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

3.  Translocation of an erythroid-specific hypersensitive site in deletion-type hereditary persistence of fetal hemoglobin.

Authors:  J T Elder; W C Forrester; C Thompson; D Mager; P Henthorn; M Peretz; T Papayannopoulou; M Groudine
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  Inactivation of human alpha-globin gene expression by a de novo deletion located upstream of the alpha-globin gene cluster.

Authors:  S A Liebhaber; E U Griese; I Weiss; F E Cash; H Ayyub; D R Higgs; J Horst
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.

Authors:  Gabriela G Loots; Michaela Kneissel; Hansjoerg Keller; Myma Baptist; Jessie Chang; Nicole M Collette; Dmitriy Ovcharenko; Ingrid Plajzer-Frick; Edward M Rubin
Journal:  Genome Res       Date:  2005-06-17       Impact factor: 9.043

6.  Characterization of a DNA binding activity in DNAse I hypersensitive site 4 of the human globin locus control region.

Authors:  M Walters; C Kim; R Gelinas
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

7.  Dissection of the enhancer activity of beta-globin 5' DNase I-hypersensitive site 2 in transgenic mice.

Authors:  D Liu; J C Chang; P Moi; W Liu; Y W Kan; P T Curtin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

8.  Transcription of the HS2 enhancer toward a cis-linked gene is independent of the orientation, position, and distance of the enhancer relative to the gene.

Authors:  S Kong; D Bohl; C Li; D Tuan
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 9.  Eukaryotic enhancers: common features, regulation, and participation in diseases.

Authors:  Maksim Erokhin; Yegor Vassetzky; Pavel Georgiev; Darya Chetverina
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

10.  Human alpha-globin gene expression is silenced by terminal truncation of chromosome 16p beginning immediately 3' of the zeta-globin gene.

Authors:  L Romao; F Cash; I Weiss; S Liebhaber; M Pirastu; R Galanello; A Loi; E Paglietti; P Ioannou; A Cao
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.